Article · 24 Jan 2024
Conference abstractPublished 15 Apr 2022
Functional connectivity in subjects with substance use disorders:A meta-analysis of functional neuroimaging studies
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: In the past decades there has been a growing number of functional connectivity studies examining brain deficits in individuals with addiction. While there is an extensive literature suggesting the major role of the brain reward pathway across substance use disorders, the role of other neural pathways remains unclear. Furthermore, little is known about shared and/or specific deficits in brain connectivity between these disorders. Methods: A coordinate-based meta-analysis was executed that aimed to examine common and specific functional connectivity alterations across substance use disorders. A total of 96 studies were included, encompassing alcohol, nicotine, cannabis and stimulant use disorders. Results Across substances, connectivity deficits were observed between ventral striatum and perigenual anterior cingulate cortex, between dorsal striatum and Brodmann areas 6/8, as well as between orbitofrontal cortex and the amygdala. Furthermore, we found that cannabis misuse was associated with increased connectivity within the inferior parietal lobule, whereas nicotine misuse was linked with decreased connectivity in the ventral striatum. Finally, cocaine and alcohol addiction were both related with dysconnectivity in the ventromedial prefrontal cortex, but showed opposite direction, namely increased and decreased connectivity, respectively. Conclusion: In this meta-analysis, we observed that substance use disorders were characterized by shared deficits between brain reward nodes and regions involved in affective processing and cognitive control. Additionally, we observed potentially specific brain targets between type of substance. In sum, these results are critical for our understanding of neural mechanisms underlying addiction. Biography Stephane Potvin is full-time professor at the Department of Psychiatry and Addiction of University of Montreal (Canada). He is coordinator of the Neuroscience and Mental Health Axis of the Centre de recherche de l'Institut Universitaire an Santé Mentale de Montréal. Since 2014, Dr Potvin is holder of the Eli Lilly Canada Chair on schizophrenia research. Dr Potvin is author of more than 200 scientific articles, including publications in prestigious journals such as American Journal of Psychiatry and Biological Psychiatry
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.
More from this journal
The newest in Journal of Neuroscience and Neuropharmacology.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Neuroscience and Neuropharmacology
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Stephane Potvin”
